{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:28:25Z","timestamp":1777490905289,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T00:00:00Z","timestamp":1301529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/gt.2011.24","type":"journal-article","created":{"date-parts":[[2011,3,31]],"date-time":"2011-03-31T10:23:16Z","timestamp":1301566996000},"page":"795-806","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE"],"prefix":"10.1038","volume":"18","author":[{"given":"J","family":"Torres-Torronteras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Eixarch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Palenzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pizzorno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Barquinero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,31]]},"reference":[{"key":"BFgt201124_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.283.5402.689","volume":"283","author":"I Nishino","year":"1999","unstructured":"Nishino I, Spinazzola A, Hirano M . Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689\u2013692.","journal-title":"Science"},{"key":"BFgt201124_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.nrl.0000106919.06469.04","volume":"10","author":"M Hirano","year":"2004","unstructured":"Hirano M, Nishigaki Y, Marti R . Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 2004; 10: 8\u201317.","journal-title":"Neurologist"},{"key":"BFgt201124_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10540-007-9043-2","volume":"27","author":"MC Lara","year":"2007","unstructured":"Lara MC, Valentino ML, Torres-Torronteras J, Hirano M, Mart\u00ed R . Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep 2007; 27: 151\u2013163.","journal-title":"Biosci Rep"},{"key":"BFgt201124_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/bmt.2010.100","volume":"46","author":"J Halter","year":"2011","unstructured":"Halter J, Sch\u00fcpbach WM, Casali C, Elhasid R, Fay K, Hammans S et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011; 46: 330\u2013337.","journal-title":"Bone Marrow Transplant"},{"key":"BFgt201124_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0005-2787(81)90174-X","volume":"654","author":"C Desgranges","year":"1981","unstructured":"Desgranges C, Razaka G, Rabaud M, Bricaud H . Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta 1981; 654: 211\u2013218.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201124_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0006-291X(03)00294-8","volume":"303","author":"R Marti","year":"2003","unstructured":"Marti R, Nishigaki Y, Hirano M . Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun 2003; 303: 14\u201318.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt201124_CR7","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1074\/jbc.M111028200","volume":"277","author":"A Spinazzola","year":"2002","unstructured":"Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002; 277: 4128\u20134133.","journal-title":"J Biol Chem"},{"key":"BFgt201124_CR8","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1016\/j.febslet.2007.06.042","volume":"581","author":"ML Valentino","year":"2007","unstructured":"Valentino ML, Mart\u00ed R, Tadesse S, L\u00f3pez LC, Manes JL, Lyzak J et al. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). FEBS Lett 2007; 581: 3410\u20133414.","journal-title":"FEBS Lett"},{"key":"BFgt201124_CR9","doi-asserted-by":"publisher","first-page":"24472","DOI":"10.1074\/jbc.M502869200","volume":"280","author":"P Ferraro","year":"2005","unstructured":"Ferraro P, Pontarin G, Crocco L, Fabris S, Reichard P, Bianchi V et al. Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 2005; 280: 24472\u201324480.","journal-title":"J Biol Chem"},{"key":"BFgt201124_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/hmg\/ddn401","volume":"18","author":"LC Lopez","year":"2009","unstructured":"Lopez LC, Akman HO, Garc\u00eda-Cazorla A, Dorado B, Mart\u00ed R, Nishino I et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet 2009; 18: 714\u2013722.","journal-title":"Hum Mol Genet"},{"key":"BFgt201124_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jconrel.2009.03.020","volume":"137","author":"C De Vocht","year":"2009","unstructured":"De Vocht C, Ranquin A, Willaert R, Van Ginderachter JA, Vanhaecke T, Rogiers V et al. Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE. J Control Release 2009; 137: 246\u2013254.","journal-title":"J Control Release"},{"key":"BFgt201124_CR12","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1212\/01.wnl.0000240853.97716.24","volume":"67","author":"M Hirano","year":"2006","unstructured":"Hirano M, Mart\u00ed R, Casali C, Tadesse S, Uldrick T, Fine B et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006; 67: 1458\u20131460.","journal-title":"Neurology"},{"key":"BFgt201124_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1212\/01.wnl.0000324602.97205.ab","volume":"71","author":"NF Moran","year":"2008","unstructured":"Moran NF, Bain MD, Muqit MM, Bax BE . Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 2008; 71: 686\u2013688.","journal-title":"Neurology"},{"key":"BFgt201124_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneur.64.3.435","volume":"64","author":"H Yavuz","year":"2007","unstructured":"Yavuz H, Ozel A, Christensen M, Christensen E, Schwartz M, Elmaci M et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007; 64: 435\u2013438.","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"BFgt201124_CR15","first-page":"A406","volume":"70","author":"M Hirano","year":"2008","unstructured":"Hirano M, Casali C, Tadesse S, Stanzani M, Savage DG . Sustained biochemical and clinical improvements two years post-allogeneic stem cell transplantation in a patient with MNGIE. Neurology 2008; 70 (Suppl 1): A406\u2013A407.","journal-title":"Neurology"},{"key":"BFgt201124_CR16","first-page":"332","volume":"73","author":"M Schupbach","year":"2009","unstructured":"Schupbach M, Benoist JF, Casali C, Elhasid R, Fay K, Hahn D et al. Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE). Neurology 2009; 73: 332\u2013332.","journal-title":"Neurology"},{"key":"BFgt201124_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1373\/clinchem.2003.026179","volume":"50","author":"R Marti","year":"2004","unstructured":"Marti R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M . Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 2004; 50: 120\u2013124.","journal-title":"Clin Chem"},{"key":"BFgt201124_CR18","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1212\/01.wnl.0000239824.95411.52","volume":"67","author":"MC Lara","year":"2006","unstructured":"Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006; 67: 1461\u20131463.","journal-title":"Neurology"},{"key":"BFgt201124_CR19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813\u20131826.","journal-title":"N Engl J Med"},{"key":"BFgt201124_CR20","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1126\/science.1070104","volume":"296","author":"A Aiuti","year":"2002","unstructured":"Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296: 2410\u20132413.","journal-title":"Science"},{"key":"BFgt201124_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009; 326: 818\u2013823.","journal-title":"Science"},{"key":"BFgt201124_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nm1393","volume":"12","author":"MG Ott","year":"2006","unstructured":"Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12: 401\u2013409.","journal-title":"Nat Med"},{"key":"BFgt201124_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415\u2013419.","journal-title":"Science"},{"key":"BFgt201124_CR24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nm.2088","volume":"16","author":"S Stein","year":"2010","unstructured":"Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, kinner A et al. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 2010; 16: 198\u2013204.","journal-title":"Nat Med"},{"key":"BFgt201124_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2009.319","volume":"18","author":"J Matrai","year":"2010","unstructured":"Matrai J, Chuah MK, Vandendriessche T . Recent advances in lentiviral vector development and applications. Mol Ther 2010; 18: 477\u2013490.","journal-title":"Mol Ther"},{"key":"BFgt201124_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1172\/JCI37630","volume":"119","author":"E Montini","year":"2009","unstructured":"Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, Ranzani M et al. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest 2009; 119: 964\u2013975.","journal-title":"J Clin Invest"},{"key":"BFgt201124_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.1083413","volume":"300","author":"X Wu","year":"2003","unstructured":"Wu X, Li Y, Crise B, Burgess SM . Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749\u20131751.","journal-title":"Science"},{"key":"BFgt201124_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jns.2004.09.034","volume":"228","author":"J Gamez","year":"2005","unstructured":"Gamez J, Lara MC, Mearin F, Oliveras-Ley C, Raguer N, Olive M et al. A novel thymidine phosphorylase mutation in a Spanish MNGIE patient. J Neurol Sci 2005; 228: 35\u201339.","journal-title":"J Neurol Sci"},{"key":"BFgt201124_CR29","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1158\/0008-5472.CAN-04-0079","volume":"64","author":"M Sugimoto","year":"2004","unstructured":"Sugimoto M, Tahara H, Ide T, Furuichi Y . Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res 2004; 64: 3361\u20133364.","journal-title":"Cancer Res"},{"key":"BFgt201124_CR30","first-page":"3687","volume":"53","author":"MH el Kouni","year":"1993","unstructured":"el Kouni MH, el Kouni MM, Naguib FN . Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. Cancer Res 1993; 53: 3687\u20133693.","journal-title":"Cancer Res"},{"key":"BFgt201124_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/jgm.951","volume":"8","author":"NW Meza","year":"2006","unstructured":"Meza NW, Puyet A, P\u00e9rez-Benavente S, Quintana-Bustamante O, Diez A, Bueren JA et al. Functional analysis of gammaretroviral vector transduction by quantitative PCR. J Gene Med 2006; 8: 1097\u20131104.","journal-title":"J Gene Med"},{"key":"BFgt201124_CR32","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1093\/nar\/gkp1141","volume":"38","author":"P Ferraro","year":"2010","unstructured":"Ferraro P et al. Quantitation of cellular deoxynucleoside triphosphates. Nucleic Acids Res 2010; 38: e85.","journal-title":"Nucleic Acids Res"},{"key":"BFgt201124_CR33","doi-asserted-by":"publisher","first-page":"12159","DOI":"10.1073\/pnas.1635259100","volume":"100","author":"G Pontarin","year":"2003","unstructured":"Pontarin G, Gallinaro L, Ferraro P, Reichard P, Bianchi V . Origins of mitochondrial thymidine triphosphate: dynamic relations to cytosolic pools. Proc Natl Acad Sci USA 2003; 100: 12159\u201312164.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201124_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248\u2013254.","journal-title":"Anal Biochem"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:21:20Z","timestamp":1648549280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,31]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFgt201124"],"URL":"https:\/\/doi.org\/10.1038\/gt.2011.24","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,31]]},"assertion":[{"value":"29 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}